Genelux Corporation (GNLX) — Stock Score Summary

Genelux Corporation (GNLX) has a MoatMap StockRank of 1/100 based on Quality (21/100), Value (31/100), and Momentum (15/100) factor scores. The current signal is STRONG SELL. Clinical-stage biopharmaceutical company with high cash burn and no commercialized products, failing the Terry Smith quality compounder test.

Genelux Corporation is a clinical-stage oncology company developing oncolytic immunotherapies for cancer treatment. Its lead product candidate, Olvi-Vec, is a modified vaccinia virus designed to selectively infect and destroy cancer cells while stimulating a systemic anti-tumor immune response. Genelux leverages its proprietary oncolytic virus platform to offer a novel mechanism of action in the challenging cancer therapeutics market, aiming to improve patient outcomes.

Key Financial Metrics

Price$2.98
Market Cap$138M
P/E (Forward)-4.04
Price/Book5.97
Return on Equity-127.3%
Return on Invested Capital-259.4%
Debt/Equity10.88
Gross Margin100.0%
Operating Margin-432112.5%
Free Cash Flow$-16M

Genelux Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Genelux Corporation’s (GNLX) StockRank?
MoatMap’s StockRank for Genelux Corporation (GNLX) is 1/100, with a Strong Sell signal. It is a composite of Quality (21), Value (31), and Momentum (15) factor ranks across MoatMap’s 19,000+ stock universe.
Does Genelux Corporation have an economic moat?
Genelux Corporation (GNLX) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Genelux Corporation a buy, hold, or sell?
MoatMap’s current signal for Genelux Corporation (GNLX) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Genelux Corporation in?
Genelux Corporation (GNLX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksGNLX deep dive reportAI ChampionsHow we score stocksSense-check another stock